semaglutide ban A South African court has ordered pharmacy group iDexis to stop selling semaglutide-based medicines. The ruling follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company A South African court has
Description
Lasting results with medical support
Community protocols use 250mcg 3x/week -- far below the 2.4mg clinical dose
Women prescribed a GLP-1 receptor agonist up to 2 years before conception were less likely to develop hypertensive disorders of pregnancy, gestational diabetes, have a preterm birth or cesarean delivery, researchers reported.“Relatively little is known how preconception GLP-1 receptor agonist use may impact pregnancy outcomes,&rdquo
Dispatches upon release
Ozempic, Wegovy, & Rybelsus lawsuits in Austin, TX claim the weight loss drugs caused gastroparesis/stomach paralysis
Interest in Retatrutide trial results is high because obesity and type 2 diabetes remain major areas of clinical research
